| Literature DB >> 28801357 |
Genita Metzler1,2, Xuezhi Dai1, Christopher D Thouvenel1, Socheath Khim1, Tania Habib3, Jane H Buckner3, David J Rawlings4,2,5.
Abstract
A common genetic variant in the gene encoding the protein tyrosine phosphatase nonreceptor type 22 (PTPN22 C1858T) has been linked to a wide range of autoimmune disorders. Although a B cell-intrinsic role in promoting disease has been reported, the mechanism(s) through which this variant functions to alter the preimmune B cell repertoire remains unknown. Using a series of polyclonal and transgenic self-reactive models harboring the analogous mutation in murine Ptpn22, we show evidence for enhanced BCR, B cell-activating factor receptor, and CD40 coreceptor programs, leading to broadly enhanced positive selection of B cells at two discrete checkpoints in the bone marrow and spleen. We further identified a bias for selection of B cells into the follicular mature versus marginal zone B cell compartment. Using a biomarker to track a self-reactive H chain in peripheral blood, we found evidence of similarly enhanced positive selection in human carriers of the PTPN22 C1858T variant. Our combined data support a model whereby the risk variant augments the BCR and coreceptor programs throughout B cell development, promoting enrichment of self-reactive specificities into the follicular mature compartment and thereby likely increasing the risk for seeding of autoimmune B cell responses.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28801357 PMCID: PMC6791366 DOI: 10.4049/jimmunol.1700601
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422